Systematic Alpha Investments’s AbbVie ABBV Stock Holding History

Systematic Alpha Investments’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$24.7M	Hold	98,285	–	–	0.66%	34
2026 Q1	$21.4M	Hold	98,285	–	–	0.75%	30
2025 Q4	$22.5M	Hold	98,285	–	–	0.7%	29
2025 Q3	$22.8M	Hold	98,285	–	–	0.75%	28
2025 Q2	$18.2M	Hold	98,285	–	–	0.65%	33
2025 Q1	$20.6M	Hold	98,285	–	–	0.79%	29
2024 Q4	$17.5M	Hold	98,285	–	–	0.64%	30
2024 Q3	$19.4M	Hold	98,285	–	–	0.71%	30
2024 Q2	$16.9M	Hold	98,285	–	–	0.64%	32
2024 Q1	$17.9M	Hold	98,285	–	–	0.72%	30
2023 Q4	$15.2M	Hold	98,285	–	–	0.68%	33
2023 Q3	$14.7M	Hold	98,285	–	–	0.73%	31
2023 Q2	$13.2M	Hold	98,285	–	–	0.64%	36
2023 Q1	$15.7M	Hold	98,285	–	–	0.82%	33
2022 Q4	$15.9M	Hold	98,285	–	–	0.8%	32
2022 Q3	$13.2M	Hold	98,285	–	–	0.8%	32
2022 Q2	$15.1M	Hold	98,285	–	–	0.85%	33
2022 Q1	$15.9M	Hold	98,285	–	–	0.78%	35
2021 Q4	$13.3M	Hold	98,285	–	–	0.62%	40
2021 Q3	$11.3M	Hold	98,285	–	–	0.49%	44
2021 Q2	$11.3M	Buy	98,285 +2,296	+2%	+$259K	0.51%	44
2021 Q1	$10.4M	Buy	95,989 +12,100	+14%	+$1.29M	0.67%	37
2020 Q4	$8.99M	Buy	+83,889	New	+$8.06M	0.98%	31

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Systematic Alpha Investments's ABBV Position: Q2 2026 in Review

Systematic Alpha Investments held its AbbVie (ABBV) position steady in Q2 2026 at 98,285 shares worth $24.7M. The position accounts for 0.66% of the portfolio, ranked #34.

Systematic Alpha Investments first reported a position in ABBV in Q4 2020 and has held it in 23 quarters since. 4,224 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Systematic Alpha Investments held 98,285 shares of AbbVie worth $24.7M as of Q2 2026.
Systematic Alpha Investments left its AbbVie share count unchanged in Q2 2026.
AbbVie made up 0.66% of Systematic Alpha Investments's portfolio in Q2 2026, its #34 holding.
Systematic Alpha Investments first reported a position in AbbVie in Q4 2020 and has held it in 23 quarters since.
4,224 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Systematic Alpha Investments's 13F filing for Q2 2026, filed 13 Aug 2026.